tradingkey.logo
tradingkey.logo
Search

EMA Says Novo Nordisk To Discontinue Marketing Of Victoza Across EU/EEA By End Of 2026

ReutersSep 5, 2025 1:42 PM
facebooktwitterlinkedin

- European Medicines Agency (EMA):

  • EMA: NOVO NORDISK WILL DISCONTINUE MARKETING OF VICTOZA ACROSS EU/EEA BY THE END OF 2026 - WEBSITE

  • EMA: NOVO NORDISK'S VICTOZA MARKETING CESSATION IS FOR COMMERCIAL REASONS & NOT CONSEQUENCE OF ANY SAFETY OR QUALITY RELATED ISSUE

  • EMA: DISCONTINUATION OF VICTOZA MAY BE A RISK OF SHORT-TERM INTERMITTENT SHORTAGES IN SOME COUNTRIES UNTIL THE PRODUCT IS NO LONGER MARKETED - WEBSITE

Further company coverage: [NOVOb.CO]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI